Profile

• PhD (Doctor of Philosophy), UCL (University College London) Medical School
  ‘’Management of Inpatient Hyponatraemia: Past, Present, and Future’’, 2018
• MSc (Hons) in Clinical Endocrinology and Diabetes, Barts & the London School of Medicine, Queen Mary University, 2014
• CCT (Certificate of Completion of Specialist Training), Endocrinology & Diabetes Mellitus, 2013
• CCT (Certificate of Completion of Specialist Training), General Internal Medicine, 2013
• ALS (Advanced Life Support), Resuscitation Council, UK, 2012
• SCE Specialty Certificate in Endocrinology & Diabetes, score 82%, Federation of the Royal Colleges of Physicians of the United Kingdom, 2011
• MRCP (UK), Member of the Royal College of Physicians (UK), 2007
• MD, University of Athens Medical School, Greece, very good, 2001

Awarded a PhD (Doctor of Philosophy) by UCL (University College London) Medical School in 2018.
The title of PhD thesis was ’Management of Inpatient Hyponatraemia: Past, Present, and Future’’.

• Sep 2017 – up to now: Private Practice
• Sep 2017 – up to now: Consultant in Endocrinology, & Diabetes
  IASO Maternity Hospital
• Feb 2015 – up to now: Consultant in Endocrinology, Diabetes & Internal Medicine
  Whittington Hospital, London
• Oct 2012 – up to now: Senior Research Associate
  Centre for Neuroendocrinology, Royal Free Campus, UCL Medical School, London
• Dec 2008 - Oct 2012: SpR Endocrinology and Diabetes (North Central London Rotation)
  Royal Free Hospital / University College London Hospital / Whittington Hospital, London
• Apr 2005 – Dec 2008: Core General Medical Training
  Leeds General Infirmary / St James’s University Hospital / University Hospital of South Manchester / Christie Hospital

During the 15 years of working in leading British teaching hospitals, he has acquired extensive experience in the management of patients with all types of endocrine disorders and diabetes mellitus.

• Apr 2014: Distinction in MSc in Clinical Endocrinology and Diabetes, Barts & the London School of Medicine, Queen Mary University
• Feb 2014: Special commendation at the 2014 BMJ awards in the ‘Diabetes Team of the Year’ category
• Apr 2010: ‘Best Patient experience’ award in Whittington Clinical Audit Awards

1. Tzoulis P, Runkle-De la Vega I.
   The Diagnostic Approach to the Patient with Hyponatremia: Are the Correct Investigations Being Done?
   Front Horm Res. 2019; 52: 190-199.
2. De Sanctis V, Soliman AT, Canatan D, Tzoulis P, et al.
   An ICET-A survey on occult and emerging endocrine complications in patients with β-thalassemia major: Conclusions and recommendations.
   Acta Biomed. 2019; 89(4): 481-489.
3. Dimakopoulou Α, Theodoraki Α, Bastianpillai C, Tzoulis P, Barnard ML, Chitale S.
   A Survey of Patient Experience in a Joint Urology-Diabetes Clinic.
   J Diabetes Treat. 2018; 3: 2574-7568.
4. Tzoulis P, Corbett RW, Ponnampalam S, Baker E, Heaton D, Doulgeraki T, Stebbing J.
   Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis.
   Endocrinol Diabetes Metab Case Rep. 2018; pii: 18-0111.
5. De Sanctis V, Soliman AT, Canatan D, Elsedfy H, Karimi M, Daar S, Rimawi H, Christou S, Skordis N, Tzoulis P, et al.
   An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report.
   Acta Biomed. 2018; 88(4): 435-444.
6. Tzoulis P, Carr H, Bagkeris E, Bouloux PM.
   Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care.
   Endocrine 2017; 55(2):539-546.
7. Zonoozi S, Barnard M, Prescott E, Jones R, Shah FT, Tzoulis P.
   Effectiveness and Safety of Sitagliptin in Patients with Beta-thalassaemia Major and Diabetes Mellitus: A Case Series.
   Mediterr J Hematol Infect Dis. 2017; 9(1): e2017004.
8. De Sanctis V, Soliman AT, Elsedfy H, Albu A, Al Jaouni S, Yaarubi SA, Anastasi S, Canatan D, Di Maio M, Di Maio S, El Kholy M, Karimi M, Khater D, Kilinc Y, Lum SH, Skordis N, Sobti P, Stoeva I, Tzoulis P, Wali Y, Kattamis C.
   The ICET-A Survey on Current Criteria Used by Clinicians for the Assessment of Central Adrenal Insufficiency in Thalassemia: Analysis of Results and Recommendations.
   Mediterr J Hematol Infect Dis. 2016; 8(1):e2016034.
9. Tzoulis P, Waung JA, Bagkeris E, Carr H, Khoo B, Cohen M, Bouloux PM.
   Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
   Clinical Endocrinology (Oxf) 2016; 84(4):620-6.
10. Tzoulis P, Bouloux PM.
    Inpatient hyponatraemia: adequacy of investigation and prevalence of endocrine causes.
    Clinical Medicine 2015; 15(1):20-4.
11. Tzoulis P, Evans R, Falinska A, Barnard M, Tan T, Woolman E, Leyland R, Martin N, Edwards R, Scott R, Gurazada K, Parsons M, Nair D, Khoo B, Bouloux PM.
    Multi-centre study of investigation and management of inpatient hyponatraemia in the UK.
    Postgraduate Medical Journal 2014; 90(1070):694-8.
12. Tzoulis P, Bagkeris E, Bouloux PM.
    A case-control study of hyponatraemia as an independent risk factor for inpatient mortality.
    Clinical Endocrinology (Oxf) 2014; 81(3):401-7.
13. Tzoulis P, Ang AL, Shah FT, Berovic M, Prescott E, Jones R, Barnard M.
    ‘Prevalence of low bone mass and vitamin D deficiency in β-thalassaemia major.’
    Hemoglobin 2014; 38(3):173-8.
14. Tzoulis P, Shah F, Jones R, Prescott E, Barnard M.
    ‘Joint Diabetes Thalassaemia Clinic: An effective new model of care.’
    Hemoglobin 2014; 38(2):104-10.
15. Ang AL, Tzoulis P, Prescott E, Davis BA, Barnard M, Shah FT.
    History of myocardial iron loading is a strong risk factor for Diabetes Mellitus and hypogonadism in adults with β thalassaemia major.
    European Journal of Haematology 2014; 92(3): 229-236.
16. Tzoulis P.
    Review of endocrine complications in adult patients with β-thalassaemia major.
    Thalassemia reports 2014; 4(3): 51-56.
17. Barnard M, Tzoulis P.
    Diabetes and thalassaemia.
    Thalassemia reports 2013; 3(1): 49-53.

• Member of the Royal College of Physicians of London
• Member of the British Society for Endocrinology
• Member of the American Endocrine Society
• Member of the European Society of Endocrinology
• Member of the Hellenic Endocrine Society
• Member of Diabetes UK
• Member of ICET-A (International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine)
• Member of UK Forum on Haemoglobin Disorders
• Member of EHN (European Hyponatraemia Network) Steering Comittee

He has been conducting clinical research for the last decade.

His research base is the Centre for Neuroendocrinology at the Royal Free Hospital and the University College London Medical School.

His academic output includes:

• 17 publications in high impact factor peer-reviewed journals (10 as first author)
• 11 presentations in British conferences
• 7 presentations in American conferences
• 7 presentations in European conferences
• 5 plenary lectures as invited speaker at major scientific events
• 2 book chapters
• Co-authorship in the British guidelines for the management of diabetes in patients with thalassaemia major

He has conceived, designed and successfully completed more than 10 clinical studies at the Royal Free and the Whittington Hospital, teaching hospitals of University College London Medical School.

His main research interests are:

• Water and electrolyte disorders
• Endocrinopathies and diabetes in thalassaemia